A previous study showed that caspase-1 activity was increased during the development of cisplatin-induced kidney injury and caspase-1-deficient mice were protected from cisplatin-induced nephrotoxicity, suggesting that caspase-1 is a key mediator of cisplatin-induced kidney injury [8]. This evidence concerns the gene CASP1 and injury.